BFC GLOBAL HEALTHCARE INVESTMENT CONFERENCE
BFC医疗健康国际商务合作投资研讨会
January 7, 2018
The St. Regis San Francisco, 125 3rd Street San Francisco, California
94103
旧金山瑞吉酒店
You are invited to attend the BFC 2018 Global Healthcare Business
Development and Investment Conference taking place on January 7 at The
St. Regis San
Francisco (http://www.starwoodhotels.com/stregis/property/overview/index.htmlpropertyID=1511
[http://www.starwoodhotels.com/stregis/property/overview/index.html?propertyID=1511]).
The conference will highlight key trends in the following areas:
*
Biotech capital market trends in both the US and China
*
Out-licensing, the emerging trend among Chinese biotech companies
*
Key success factors for Nasdaq listing of a Chinese biotech company
*
Leading biotech company presentations
Senior executives from more than 100 public & private healthcare
companies across the biopharmaceuticals, IVD, medical device, and
healthcare services sectors will attend this event. More than 100 PE
and VC investors from over 100 firms will also attend.
The conference will provide an optimal environment for networking with
the senior executives of your potential partners. Company management
teams and investors will also have the opportunity to participate in
one-on-one and small group meetings through BFC Group.
AGENDA:
8:00 – 9:00 Registration
9:00 – 9:15 Opening Remark
* Speaker: David Chen, Managing Director, BFC Group
9:15 – 10:15 State of Healthcare Investment in China and US
* Moderator: David Wang, Managing Partner, OrbiMed Asia
* Panelists:
* Min Fang, Managing Director, Warburg Pinkus
* Lu Huang, Morningside Venture
* Lilly Han, Partner, Sunshine Insurance
* Jack Yin, Executive Director, SDIC Fund
* Jin Wan, Executive Director, SDIC Venture Capital
10:00 – 11:00 Road to a Successful US IPO in the Current Market
Environment
* Moderator: Charlie Kim
* Panelists:
* Katherine Xu, Partner and Co-Head of the Biopharmaceutical Equity
Research Group, William Blair
* John Whittaker, Executive Director, J.P. Morgan Investment Bank,
Equity Capital Markets, J.P. Morgan Chase & Co.
* David Ke, Vice President at J.P. Morgan Investment Bank, Equity
Capital Markets, J.P. Morgan Chase & Co.
* Lili Zheng, Managing Partner, Deloitte
11:00 – 11:30 Tea Break
11:30 – 12:30 Selling to the West – Seeking Out-licensing
Opportunities to Major Biopharma Companies in the West
* Moderator: Christina Zhang, Partner and Chief Representative of
Shanghai Office, Cooley
* Speaker:
* Vice President, Corporate Development at Gilead Sciences (Invited)
* VP of Business Development, AbbVie (Invited)
* VP of Business Development, Celgene (Invited)
* Syed Kazmi, Executive Director of Business Development, Amgen
(Invited)
* Barbara Kosacz, Partner, Cooley
12:30 – 14:00 Lunch Break
14:00 – 15:30 Mini Company Road Show
* Moderator: Kevin Chen, Partner, Founding
Partner, Biotrack Capital
15:30 – 16:00 Tea Break
16: 00 – 17:00 Searching for the Dream Deals in US and China
* Moderator: Ben Qiu, Partner, Advantech
* Panelists:
* Fei Chen, Partner, Lilly Asia Ventures
* Partner, YF Capital
* Partner, Beta Pharma
* Chief Business Officer, Biontech (Germany)
* Leading biotech company in US
17: 00 – 18:00 Wine Reception
For questions, please email: conference@bfcgroup.biz
With kindest regards,
Organizing Committee, BFC Healthcare Business Development and
Investment Conference
trade shows
business
courses
conventions
Start Up
food
wine
172
Views
08/01/2018 Last update